Inicio
AL

Ai Ling Cheah

494
18
3

Sobre el Miembro

Biografía

Ms. Cheah is a dedicated researcher and regulatory affairs specialist with a passion for addressing regulatory challenges and advancing control release systems in the pharmaceutical industry. With a comprehensive background in pharmaceutical legislation, quality assurance, and regulatory affairs, Ms. Cheah brings a wealth of expertise to the field. Ms. Cheah holds a Master's degree in Pharmaceutical Legislation and Regulatory Control, specializing in Malaysian pharmacy legislation and policy. Her research interests revolve around exploring innovative solutions to regulatory challenges in drug delivery systems, particularly focusing on controlled release formulations. Through her experience in the pharmaceutical industry, Ms. Cheah has developed a deep understanding of regulatory requirements and compliance standards, ensuring the quality and safety of pharmaceutical products. With a strong commitment to continuous learning and professional development, Ms. Cheah remains actively engaged in ongoing research projects and collaborative initiatives within the pharmaceutical community. By contributions to regulatory affairs and control release system research, Ms. Cheah strives to make a meaningful impact on the pharmaceutical industry and improve patient outcomes worldwide. Ms. Cheah welcomes opportunities for collaboration and knowledge exchange, aiming to further their research interests and contribute to advancements in regulatory science and drug delivery systems.

Educación

  • University of Malaya
    Título Masters in Pharmaceutical Legislation and Regulatory Control
    Campo de estudio Department of Pharmaceutical Technology
    Fecha de inicio 01/2023
    Fecha de fin 01/2024
  • National University of Malaysia
    Título Bachelor of Science with Hons (Biochemistry)
    Campo de estudio Department of Biology and Biotechnology
    Fecha de inicio 01/2018
    Fecha de fin 01/2022

Experiencia

UL

Researcher (Visitor)

Uddin Lab •

01/2024 – 01/2024 •